A carregar...

Dose-Dependent Regulation of High-Density Lipoprotein Metabolism with Rosuvastatin in the Metabolic Syndrome

Background: Low plasma concentration of high-density lipoprotein (HDL) cholesterol is a risk factor for cardiovascular disease and a feature of the metabolic syndrome. Rosuvastatin has been shown to increase HDL cholesterol concentration, but the mechanisms remain unclear. Methods and Results: Twelv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ooi, Esther M. M., Watts, Gerald F., Nestel, Paul J., Sviridov, Dmitri, Hoang, Anh, Barrett, P. Hugh R.
Formato: Artigo
Idioma:Inglês
Publicado em: The Endocrine Society 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2729151/
https://ncbi.nlm.nih.gov/pubmed/18029469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2007-0854
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!